3rd Targeted Protein Degradation Summit

Off the back of the newly released first-in-human data utilizing PROTACs, it is more than ever evident that the field of targeted protein degradation is redefining the therapeutic landscape across the whole of the pharmaceutical industry. Despite the recent success, significant challenges are continuing to hold back the progress of the discovery and development of safe and effective protein degraders.

For the 3^rd time, the TPD Summit is providing you with the leading platform that showcases the latest developments and advancements in the field, bringing together the leading biopharmaceutical and academic organizations in an intimate networking environment to focus on successfully degrading intracellular & extracellular targets, improving rational design and accelerating the translation of next generation proteasomal- & autophagy- mediated protein degraders into clinical trials.

Here is a sneak peak of just some of our 60+ world-class speaker faculty:

• Jay Bradner, President, Novartis Institutes for Biomedical Research
• Craig Crews, John C. Malone Professor of MCDB, Chemistry & Pharmacology, Yale University
• Alessio Ciulli, Professor of Chemical & Structural Biology, University of Dundee
• Matt Disney, Professor of Chemistry & Neuroscience, Scripps Research
• Ian Churcher, Chief Scientific Officer, Amphista Therapeutics
• John Houston, President & Chief Executive Officer, Arvinas
• Ray Deshaies, Senior Vice President of Global Research, Amgen
• Nello Mainolfi, Founder, President & Chief Executive Officer, Kymera Therapeutics
• Stewart Fisher, Chief Scientific Officer, C4 Therapeutics
• Scott Edmondson, Director & Head of Boston Oncology Chemistry, AstraZeneca
• Yu Shen, Director of Cancer Biology, AbbVie
• Richard Glynne, Chief Scientific Officer, Lycia Therapeutics
• Ingrid Wertz, Principal Scientist & Project Team Lead, Genentech

Don’t miss the most comprehensive, industry-focused meeting in the field specifically dedicated to the discovery and development of targeted protein degradation strategies to advance your pipelines towards success!